Legend Biotech Corp Transaction Price Allocated To Remaining Performance Obligations
Legend Biotech Corp (LEGN) had Transaction Price Allocated To Remaining Performance Obligations of $303.22 million as of 2021-12-31, per its 20-F filed 2022-03-31.
Discontinued › Notes
ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations · last filed 2022-03-31
- 2021-12-31: Transaction Price Allocated To Remaining Performance Obligations $303.22M.
- 2021-06-30: Transaction Price Allocated To Remaining Performance Obligations $308.77M.
- 2020-12-31: Transaction Price Allocated To Remaining Performance Obligations $330.08M.
- 2019-12-31: Transaction Price Allocated To Remaining Performance Obligations $324.06M.
| Period end | Transaction Price Allocated To Remaining Performance Obligations |
|---|---|
| 2021-12-31 | $303.22M 20-F · filed 2022-03-31 |
| 2021-06-30 | $308.77M 6-K · filed 2021-08-23 |
| 2020-12-31 | $330.08M 20-F · filed 2022-03-31 |
| 2019-12-31 | $324.06M 20-F · filed 2022-03-31 |
| 2018-12-31 | $322.23M 20-F · filed 2021-04-02 |